CLINICAL TRIALS PROFILE FOR MOUNJARO
✉ Email this page to a colleague
All Clinical Trials for MOUNJARO
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT05708859 ↗ | Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT | Not yet recruiting | Eli Lilly and Company | Phase 4 | 2023-02-01 | A multi-center, randomized, double-blind, placebo-controlled, parallel-group phase IV Study evaluating the effects of tirzepatide on atherosclerotic plaque progression assessed by coronary computed tomography angiography (CCTA) in participants with a diagnosis of type II Diabetes (T2DM) and atherosclerosis. |
NCT05708859 ↗ | Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT | Not yet recruiting | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Phase 4 | 2023-02-01 | A multi-center, randomized, double-blind, placebo-controlled, parallel-group phase IV Study evaluating the effects of tirzepatide on atherosclerotic plaque progression assessed by coronary computed tomography angiography (CCTA) in participants with a diagnosis of type II Diabetes (T2DM) and atherosclerosis. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for MOUNJARO
Condition Name
Clinical Trial Locations for MOUNJARO
Trials by Country
Clinical Trial Progress for MOUNJARO
Clinical Trial Phase
Clinical Trial Sponsors for MOUNJARO
Sponsor Name